Vaccination coverage rates and attitudes towards mandatory vaccinations among healthcare personnel in tertiary-care hospitals in Greece.


Journal

Expert review of vaccines
ISSN: 1744-8395
Titre abrégé: Expert Rev Vaccines
Pays: England
ID NLM: 101155475

Informations de publication

Date de publication:
06 2022
Historique:
pubmed: 7 4 2022
medline: 15 6 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

Our aim was to estimate vaccination and susceptibility rates against vaccine-preventable diseases among healthcare personnel (HCP) in eight hospitals. Cross-sectional survey. A total of 1284 HCP participated (physicians: 31.3%, nursing personnel: 36.6%, paramedical personnel: 11.1%, administrative personnel: 13.2%, supportive personnel: 7.3%). Vaccination rates were 32.9% against measles and mumps, 38.1% against rubella, 5.7% against varicella, 9.2% against hepatitis A, 65.8% against hepatitis B, 31.8% against tetanus-diphtheria, 7.1% against pertussis, 60.2% against influenza, and 80.1% against COVID-19. Susceptibility rates were as follows: 27.8% for measles, 39.6% for mumps, 33.4% for rubella, 22.2% for varicella, 86.3% for hepatitis A, 34.2% for hepatitis B, 68.2% for tetanus-diphtheria, and 92.9% for pertussis. Older HCP had higher susceptibility rates against mumps, rubella, varicella, hepatitis A, hepatitis B, tetanus-diphtheria, and pertussis (p-values <0.001 for all). Mandatory vaccinations were supported by 81.85% of HCP. Although most HCPs supported mandatory vaccinations, significant vaccination gaps, and susceptibility rates were recorded. The proportion of susceptible HCP to measles, mumps, rubella, and varicella has increased in the past decade, mostly because of reduction in acquired cases of natural illness. Vaccination programs for HCP should be developed. A national registry to follow HCP's vaccination rates is urgently needed.

Identifiants

pubmed: 35382665
doi: 10.1080/14760584.2022.2063118
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

853-859

Auteurs

Helena C Maltezou (HC)

Directorate of Research, Studies, and Documentation, National Public Health Organization, Athens, Greece.

Maria Tseroni (M)

Directorate of Epidemiological Surveillance of Infectious Diseases, National Public Health Organization, Athens, Greece.

Ioannis Drositis (I)

Medical Oncology Department, Venizeleio-Pananeio General Hospital, Heraklion, Greece.

Maria N Gamaletsou (MN)

Pathophysiology Department, Medical School, National and Kapodistrian University of Athens, and General Hospital of Athens Laiko, Athens, Greece.

Dimitra Maria Koukou (DM)

First Department of Pediatrics, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.

Emmanouil Bolikas (E)

Infection Control Committee, Venizeleio-Pananeio General Hospital, Heraklion, Greece.

Emmanuela Peskelidou (E)

COVID-19 Intensive Care Unit, 424 General Military Hospital of Thessaloniki, Thessaloniki, Greece.

Charalambos Daflos (C)

Infection Control Committee, Korgialeneio-Benakeio Red Cross General Hospital, Athens, Greece.

Evangelia Panagiotaki (E)

Department of Microbiology, Venizeleio-Pananeio General Hospital, Heraklion, Greece.

Caterina Ledda (C)

Occupational Medicine Unit, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Androula Pavli (A)

Department for Travel Medicine, National Public Health Organization, Athens, Greece.

Nikolaos Moussas (N)

Internal Medicine and Infectious Diseases Clinic, Iatriko Athinon General Hospital, Athens, Greece.

Stavroula Kontogianni (S)

Department of Pediatrics, University of Thessaly, Larissa, Greece.

Eftychia Svarna (E)

Department of Pediatrics, University of Thessaly, Larissa, Greece.

Michalis Ploumidis (M)

Infectious Diseases Unit, First Department of Internal Medicine, Gennimatas General Hospital, Athens, Greece.

Andronikos Spyrou (A)

Infectious Diseases Unit, First Department of Internal Medicine, Gennimatas General Hospital, Athens, Greece.

Maria Chini (M)

Third Department of Internal Medicine and Infectious Diseases Unit, Korgialeneio-Benakeio Red Cross Hospital, Athens, Greece.

Georgios Adamis (G)

Infectious Diseases Unit, First Department of Internal Medicine, Gennimatas General Hospital, Athens, Greece.

Athanasia Lourida (A)

Infection Prevention and Control Committee, Aghia Sofia Children's Hospital, Athens, Greece.

Dimitrios Hatzigeorgiou (D)

Medical Directorate, Hellenic Air Force General Staff, Athens, Greece.

Panagiotis Gargalianos (P)

Internal Medicine and Infectious Diseases Clinic, Iatriko Athinon General Hospital, Athens, Greece.

George Syrogiannopoulos (G)

Department of Pediatrics, University of Thessaly, Larissa, Greece.

Nikolaos V Sipsas (NV)

Pathophysiology Department, Medical School, National and Kapodistrian University of Athens, and General Hospital of Athens Laiko, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH